PODCAST

Diagnostics Dialogues

questdialogues

Thought leaders discuss hot topics for hospitals and health systems, share cutting-edge research, and identify what’s next in diagnostic medicine.
Start Here
The power of laboratory analytics
The power of laboratory analytics
Diagnostics is the thread that connects the entire healthcare ecosystem and patient care continuum. And the laboratory generates an immense amount of data that can help enable improvements in both patient and hospital health. By better leveraging laboratory analytics, health systems and clinicians can identify, stratify, and prioritize patient populations to improve their health and the overall quality of care. In this session, Dr Waheed and Dr Hilborne discuss: System-level strategies that can deliver meaningful, credible data to clinicians to align goals and drive meaningful, collaborative discussions across your health systemsChange management approaches that can bring together physicians, patients, laboratorians, and other key stakeholders to drive effective test utilization strategies and reduce physician burnoutWays to approach and exercise leadership around the concept of lab stewardship within the overall delivery of care, as well as practice of pathology and laboratory medicineOpportunities to leverage Quest’s vast patient-centric data set to inform standard of care expectations, risk stratification, and healthy equity improvements   Rehan Waheed, MD Senior Medical Director & Chief Medical Informatics Officer, Healthcare Analytics Solutions, Quest Diagnostics Dr Rehan Waheed joined Quest Diagnostics in 2021 as Senior Medical Director & Chief Medical Informatics Officer for Healthcare Analytics Solutions. In this leadership role at the critical intersection of medicine, informatics, and business, he oversees clinical expertise for Quest’s healthcare analytics solutions while also championing important initiatives to advance analytics in public health. Dr Waheed is an advocate for action, leverages knowledge from other industries and is a proponent of value-based, patient-centered healthcare leveraging health information technology. Prior to joining Quest, Dr Waheed was a Director at Cerner Corporation leading efforts in the federal sector. Other past roles include Sr. Director in the Department of Integration & Transformation (DoIT) at The MetroHealth System, Sr. Consultant for Better Health Partnership, and Medical Officer at the Louis Stokes Cleveland VA Medical Center. He is board-certified in Internal Medicine, he has a Lean Six Sigma Black Belt, Informatics Certificate and Emotionally Intelligent Leadership Certificate from CWRU Weatherhead School of Management. He continues to teach as an adjunct faculty at Baldwin Wallace and guest lecturer for other universities. Lee H. Hilborne, MD, MPH Professor of Pathology and Laboratory Medicine, UCLA Senior National Medical Director, Quest Diagnostics  Dr Hilborne is Professor of Pathology and Laboratory Medicine at the David Geffen School of Medicine at UCLA; Senior National Medical Director for Quest Diagnostics; and a Health Services Researcher at the RAND Corporation in Santa Monica. Dr Hilborne served as a member of the ASCP Board of Directors for 18 years, was president from 2007-2008 and, for nine years, was a member of the Board of Governors for ASCP’s Board of Certification. He chairs the ASCP Effective Test Utilization Subcommittee and is a member of the Commissions on Membership and Public Policy. For the past eight years, Dr Hilborne has been a member of Venice Family Clinic’s Medical Practice Committee.
Nov 12 2021
31 mins
Trends in drug testing resulting from the COVID-19 pandemic
The convergence of the opioid epidemic and the coronavirus disease 2019 (COVID-19) pandemic has created new healthcare challenges. Health systems, from a system- and individual clinician-level, are more important than ever in the pursuit of addressing the epidemic within the pandemic. In this session, Dr Gudin discusses: Recently-published data by Quest that demonstrates decreased drug testing overall, with increased positivity for high-risk drugs and dangerous drug combinations Tools and practices for clinicians to assess and stratify patients for potential prescription drug abuseSystem-level strategies that employ an integrated care delivery approach, including leveraging community and diagnostics partnerships, to support impacted patient populations Jeffrey Gudin, MD; Executive Director, Medical Affairs, Drug Monitoring & Toxicology Dr Gudin is an active speaker and advisor whose clinical and research interests include postoperative pain management; opioid abuse, and potential solutions; and increasing clinical awareness of pain assessment and risk management. Board-certified in pain management, addiction medicine, and hospice and palliative medicine, Dr Gudin is also a medical acupuncturist. He serves as co-Editor-at-Large for Practical Pain Management. ----more---- ------------------------------ Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve healthcare management. Quest Diagnostics annually serves 1 in 3 adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.   More information is available at www.QuestDiagnostics.com
Aug 25 2021
38 mins
Patient-minded Neurology
This episode features Dr Michael Racke discussing the evolution of treating neurologic disease to detect disease early and focus on prevention.  In this session, Dr Racke discusses: How diagnostics and treatment has evolved for multiple sclerosisTreating patients at the first incidence of neurologic disease for optimal outcomesHow health systems can address the needs of patients with complex neurologic conditions to minimize the human and economic toll of disease Michael Racke MD Bio:   Dr Michael K. Racke is Medical Director for Neurology at Quest Diagnostics. Dr Racke is a leader in the field of neurology and neuroimmunology. Dr Racke is the author of more than 200 peer-reviewed papers, book chapters, and reviews spanning the pathogenesis of neuroimmunologic diseases. He continues to serve on several national professional society committees. ----more----   ------------------------------ Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve healthcare management. Quest Diagnostics annually serves 1 in 3 adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.   More information is available at www.QuestDiagnostics.com
Jun 11 2021
39 mins
Optimize Oncology Care with Clinical Pathways
This episode features Yuri Fesko MD, with clinical pathways to help guide diagnosis and treatment in oncology. In this session, Dr Fesko discusses: How clinical pathways can make an impact for hospitals to improve oncology outcomesThe critical importance of collaboration for pathologists and oncologistsThe future of oncology care in integrated health systems Yuri Fesko MD Bio: Dr Yuri Fesko serves as the Executive Medical Director of Medical Affairs at Quest Diagnostics, and the Chief Clinical Officer for Oncology Strategic Collaboration at Quest. Born and raised in New York City, Dr Fesko trained at Case Western Reserve University, and completed his fellowship at University Hospitals of Cleveland. After his fellowship, Dr Fesko served as the Chief of Community Oncology for Wake County through Duke University Health System.An experienced oncologist and medical business leader, he is currently responsible for strategic clinical development at Quest across multiple functional areas including Regulatory FDA, HEOR, and R&D. ----more----   ------------------------------ Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve healthcare management. Quest Diagnostics annually serves 1 in 3 adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
May 12 2021
27 mins
COVID-19: Supporting Safety for the Front Line
Today’s podcast features Dr Nicholaos Bellos with strategies that are helping some health systems best operate in today's healthcare environment. In this session, Dr Bellos discusses: The ease of viral transmission and what health systems can do to mitigate riskDiagnostic solutions, guidelines, and best practices to ensure safety for the front lineThe future of health systems in the post-pandemic landscape Nicholaos Bellos MD Bio: Board-certified in internal medicine and infectious disease, Dr Nicholaos Bellos brings both deep clinical knowledge and executive leadership experience to the discussion. Drawing from his passion for advancing positive outcomes for patients, his expertise includes delivering evidence-based, measurable healthcare solutions that contain costs, reduce hospital length-of-stay and readmissions, and cut down on hospital-acquired drug-resistant infections. Dr Bellos maintains a private clinical practice of over 20 years, as well as serving as national medical director, extended care services at Quest Diagnostics. Previously, he was associate vice president of medical operations and performance management and innovation at Tenet Health. ----more----   ------------------------------ Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve healthcare management. Quest Diagnostics annually serves 1 in 3 adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.   More information is available at www.QuestDiagnostics.com
Apr 7 2021
23 mins
About Diagnostics Dialogues from Quest Diagnostics

0:00